Gary R. Pasternack

4.6k total citations · 1 hit paper
57 papers, 3.8k citations indexed

About

Gary R. Pasternack is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Gary R. Pasternack has authored 57 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 15 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Gary R. Pasternack's work include Ubiquitin and proteasome pathways (11 papers), Cancer, Lipids, and Metabolism (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Gary R. Pasternack is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), Cancer, Lipids, and Metabolism (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Gary R. Pasternack collaborates with scholars based in United States and Egypt. Gary R. Pasternack's co-authors include Francis P. Kuhajda, Ellen S. Pizer, Randolph A. Hennigar, James D. Dick, Lee A. Witters, Jonathan R. Brody, Shrihari S. Kadkol, Thomas L. Leto, Richard A. Anderson and Vincent T. Marchesi and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Gary R. Pasternack

55 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fatty acid synthesis: a potential selective target for antineoplastic therapy.

1994 577 citations Francis P. Kuhajda, Gary R. Pasternack et al. profile →

Peers

Gary R. Pasternack

MB

CR

ONCOL

IMMUN

SURGE

Ellen S. Pizer United States

Pasquale Chieco Italy

Catherine A. Reznikoff United States

Hitoshi Akedo Japan

Junji Magae Japan

Sybille Mazurek Germany

Atul Bedi United States

Tzuling Cheng United States

Sucheta Telang United States

Hsiang‐Fu Kung Hong Kong

Ellen S. Pizer United States

Gary R. Pasternack

3.1k ×1.2

MB

2.5k ×1.5

CR

760 ×1.3

ONCOL

326 ×0.7

IMMUN

687 ×1.5

SURGE

Citations per year, relative to Gary R. Pasternack Gary R. Pasternack (= 1×) peers Ellen S. Pizer

Countries citing papers authored by Gary R. Pasternack

Since Specialization

Citations

This map shows the geographic impact of Gary R. Pasternack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Pasternack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Pasternack more than expected).

Fields of papers citing papers by Gary R. Pasternack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary R. Pasternack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Pasternack. The network helps show where Gary R. Pasternack may publish in the future.

Co-authorship network of co-authors of Gary R. Pasternack

This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Pasternack. A scholar is included among the top collaborators of Gary R. Pasternack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Pasternack. Gary R. Pasternack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Pasternack, Gary R., et al.. (2025). Cholic acid as a treatment for cerebrotendinous xanthomatosis: a comprehensive review of safety and efficacy. Orphanet Journal of Rare Diseases. 20(1). 387–387.

2.

Rashid, Mohammed H., Gary R. Pasternack, Chythanya Rajanna, et al.. (2011). Enumeration of bacteriophage particles. PubMed. 1(2). 86–93. 132 indexed citations

3.

Brody, Jonathan R., Agnes Witkiewicz, Timothy K. Williams, et al.. (2007). Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia. Modern Pathology. 20(12). 1238–1244. 18 indexed citations

4.

Pasternack, Gary R., et al.. (2005). Phosphorylated Retinoblastoma Protein Complexes with pp32 and Inhibits pp32-mediated Apoptosis. Journal of Biological Chemistry. 280(16). 15497–15502. 35 indexed citations

5.

Pasternack, Gary R., et al.. (2005). A pp32–retinoblastoma protein complex modulates androgen receptor-mediated transcription and associates with components of the splicing machinery. Biochemical and Biophysical Research Communications. 334(2). 702–708. 12 indexed citations

6.

Brody, Jonathan R., et al.. (2004). Identification of a functional mutation in pp32r1 (ANP32C). Human Mutation. 23(6). 546–551. 7 indexed citations

7.

Kadkol, Shrihari S., et al.. (2001). Expression of pp32 gene family members in breast cancer. Breast Cancer Research and Treatment. 68(1). 65–73. 28 indexed citations

8.

Bai, Jining, Jonathan R. Brody, Shrihari S. Kadkol, & Gary R. Pasternack. (2001). Tumor suppression and potentiation by manipulation of pp32 expression. Oncogene. 20(17). 2153–2160. 62 indexed citations

9.

Brody, Jonathan R., et al.. (1999). Identification of Sequences Required for Inhibition of Oncogene-mediated Transformation by pp32. Journal of Biological Chemistry. 274(29). 20053–20055. 49 indexed citations

10.

Kadkol, Shrihari S., Jonathan R. Brody, Jonathan Pevsner, Jining Bai, & Gary R. Pasternack. (1999). Modulation of oncogenic potential by alternative gene use in human prostate cancer. Nature Medicine. 5(3). 275–279. 45 indexed citations

11.

Pizer, Ellen S., Sigurd Lax, Francis P. Kuhajda, Gary R. Pasternack, & Robert J. Kurman. (1998). Fatty acid synthase expression in endometrial carcinoma. Cancer. 83(3). 528–537. 138 indexed citations

12.

Pizer, Ellen S., Sigurd Lax, Francis P. Kuhajda, Gary R. Pasternack, & Robert J. Kurman. (1998). Fatty acid synthase expression in endometrial carcinoma. Cancer. 83(3). 528–537. 1 indexed citations

13.

Kadkol, Shrihari S., Jonathan R. Brody, Jonathan I. Epstein, Francis P. Kuhajda, & Gary R. Pasternack. (1998). Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer. The Prostate. 34(3). 231–237. 45 indexed citations

14.

Chen, Tseng-hui Timothy, et al.. (1996). Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci.. Molecular Biology of the Cell. 7(12). 2045–2056. 70 indexed citations

15.

Chen, Tseng-hui Timothy, et al.. (1996). pp32 overexpression induces nuclear pleomorphism in rat prostatic carcinoma cells. Cell Proliferation. 29(12). 643–653. 7 indexed citations

16.

Pizer, Ellen S., et al.. (1996). Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.. PubMed. 56(12). 2745–7. 237 indexed citations

17.

Holthöfer, Harry, Bradley A. Schulte, Gary R. Pasternack, G. J. Siegel, & S. S. Spicer. (1987). Three distinct cell populations in rat kidney collecting duct. American Journal of Physiology-Cell Physiology. 253(2). C323–C328. 52 indexed citations

18.

Pasternack, Gary R., Ralph Snyderman, M C Pike, Robert J. Johnson, & H. S. Shin. (1978). Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.. The Journal of Experimental Medicine. 148(1). 93–102. 27 indexed citations

19.

Johnson, Robert J., Gary R. Pasternack, & Hyun S. Shin. (1977). Antibody-mediated suppression of tumor growth. I. Suppression by murine IgG1 isolated from alloantiserum.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 118(2). 489–93. 13 indexed citations

20.

Pasternack, Gary R., et al.. (1977). Antibody-Mediated Suppression of Tumor Growth. The Journal of Immunology. 118(2). 489–493. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact